Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance.

Chemotherapy employs anti-cancer drugs to stop the growth of cancerous cells, but one common obstacle to the success is the development of chemoresistance, which leads to failure of the previously effective anti-cancer drugs. Resistance arises from different mechanistic pathways, and in this critical review, we focus on the Fanconi Anemia (FA) pathway in chemoresistance. This pathway has yet to be intensively researched by mainstream cancer researchers. This review aims to inspire a new thrust toward the contribution of the FA pathway to drug resistance in cancer. We believe an indepth understanding of this pathway will open new frontiers to effectively treat drug-resistant cancer. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Citation

Kajal Ghosal, Christian Agatemor, Richard I Han, Amy T Ku, Sabu Thomas, Sudit Mukherjee. Fanconi Anemia DNA Repair Pathway as a New Mechanism to Exploit Cancer Drug Resistance. Mini reviews in medicinal chemistry. 2020;20(9):779-787

Mesh Tags

Substances

PMID: 31902358

search → result